Bunker CB. Dermatoses of male genitalia. In: Burns T, Breathnach S, Bleiker T, et al, eds. Rook’s textbook of dermatology. 9th ed. New York, NY: Wiley-Blackwel; 2014.
Edwards S, Bunker C, Ziller F, et al. 2013 European guideline for the management of balanoposthitis. Int J STD AIDS. 2014;25:615-626.
Bunker CB. Diseases and disorders of the male genitalia. In: Fitzpatrick's dermatology in general medicine. New York, NY: McGraw-Hill; 2003: Chapter 3.
1. Bunker CB. Dermatoses of male genitalia. In: Burns T, Breathnach S, Bleiker T, et al, eds. Rook’s textbook of dermatology. 9th ed. New York, NY: Wiley-Blackwel; 2014.
2. Edwards S, Bunker C, Ziller F, et al. 2013 European guideline for the management of balanoposthitis. Int J STD AIDS. 2014;25:615-626.
3. English JC, Laws RA, Keough GC, et al. Dermatoses of the glans penis and prepuce. J Am Acad Dermatol. 1997;37:1-24.
4. Wakatsuki A. Clinical experience of streptococcal balanoposthitis in 47 healthy adult males. Hinyokika Kiyo. 2005;51:737-740.
5. Cusano F, Capozzi M. Photocontact dermatitis from ketoprofen with cross-reactivity to ibuproxam. Contact Dermatitis. 1992;27:50-59.
6. Lyon CC, Kulkarni J, Zimerson E, et al. Skin disorders in amputees. J Am Acad Derm. 2000;42:501-507.
7. Gamulka BD. Index of suspicion. Case #1. Diagnosis: allergic contact dermatitis. Pediatr Rev. 2000;21:421-426.
8. Ramam M, Khaitan BK, Singh MK, et al. Frictional sweat dermatitis. Contact Dermatitis. 1998;38:49.
9. Jacobson MA. Review of the toxicities of foscarnet. J Acquir Immune Defic Syndr. 1992;5:11-17.
10. Birley HDL, Walker MM, Luzzi GA, et al. Clinical features and management of recurrent balanitis; association with atopy and genital washing. Genitourin Med. 1993;69:400-403.
11. Reiter H. Ueber eine bisher unerkannte. Dtsch Med Woschensch. 1916;42:1535-1536.
13. Meffert JJ, Davis BM, Grimwood. Lichen sclerosus. J Am Acad Dermatol. 1995;32:393-416.
14. Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet. 1999;22:1777-1783.
15. Bunker CB. Diseases and disorders of the male genitalia. In: Fitzpatrick's dermatology in general medicine. New York, NY: McGraw-Hill; 2003: Chapter 3.
16. Riddell L, Edwards A, Sherrard J. Clinical features of lichen sclerosus in men attending a department of genitourinary medicine. Sex Transm Infect. 2000;76:311-313.
17. Pelisse M. Lichen sclerosus. Ann Dermatol Venereol. 1987;114:411-419.
18. Feldmann R, Harms M. Lichen sclerosus et atrophicus. Hautarzt. 1991;42:147-153.
19. Datta C, Dutta SK, Chaudhuri A. Histopathological and immunological studies in a cohort of balanitis xerotica obliterans. J Indian Med Assoc. 1993;91:146-148.
20. Bunker CB. Topics in penile dermatology. Clin Exp Dermatol. 2001;26:469-479.
21. Edmonds EV, Hunt S, Hawkins D, et al. Clinical parameters in male genital lichen sclerosus: a case series of 329 patients. J Eur Acad Dermatol Venereol. 2012;26:730-737.
22. Edmonds EV, Oyama N, Chan I, et al. Extracellular matrix protein 1 autoantibodies in male genital lichen sclerosus. Br J Dermatol. 2011;165:218-219.
23. Edmonds EV, Bunker CB. Nuclear magnetic resonance spectroscopy of urine in male genital lichen sclerosus. Br J Dermatol. 2010;163:1355-1356.
24. Bunker CB, Patel N, Shim TN. Urinary voiding symptomatology (micro-incontinence) in male genital lichen sclerosus. Acta Derm Venereol. 2013;93:246-248.
25. Edmonds E, Barton G, Buisson S, et al. Gene expression profiling in male genital lichen sclerosus. Int J Exp Pathol. 2011;92:320-325.
26. Zoon JJ. Balanoposthite chronique cironscrite benigne a plasmocytes. Dermatologica. 1952;105:1-7.
27. Zoon JJ. Verenigingsverslagen. Ned Tijdschr Geneeskd. 1950;94:1528-1530.
28. Altmeyer P, Kastner U, Luther H. Balanitis/balanoposthitis chronica circumscripta benigna plasmacellularis - entity or fiction? Hautarzt. 1998;49:552-555.
29. Bunker CB. Review of dermatology journals. Sex Transm Infect. 1999;75:281-282.
30. Yoganathan S, Bohl TG, Mason G. Plasma cell balanitis and vulvitis (of Zoon). J Reprod Med. 1994;39:939-944.
31. Kiene P, Folster-Holst R. No evidence of human papillomavirus infection in balanitis circumscripta plasmacellularis Zoon. Acta Derm Venereol. 1995;75:496-497.
32. Catterall RD. In: Winner HL, Hurley R, eds. Symposium on candida infections. Edinburgh, UK: Livingstone; 1966:113.
33. Odds FC. Genital candidiasis. Clin Exp Dermatol. 1982;7:345-354.
34. Bunker CB. Re: Malignant and premalignant lesions of the penis. BMJ. 2013;346:f1149.
35. Bunker CB. Malignant and premalignant lesions of the penis: penile cancer can be prevented or treated pre-emptively. BMJ. 2013;346:f2129.
36. Eisendle K, Grabner T, Kutzner H, et al. Possible role of Borrelia burgdorferi sensu lato infection in lichen sclerosus. Arch Dermatol. 2008;144:591-598.
37. Morris BJ, Krieger JN. Penile inflammatory skin disorders and the preventive role of circumcision. Int J Prev Med. 2017;8:32.
38. Mallon E, Hawkins D, Dinneen M, et al. Circumcision and genital dermatoses. Arch Dermatol. 2000;136:350-354.
39. Morris BJ. Why circumcision is a biomedical imperative for the 21st century. Bioessays. 2007;29:1147-1158.
40. Doiron PR, Bunker CB. Obesity-related male genital lichen sclerosus. J Eur Acad Dermatol Venereol. 2017;31(5):876-879.
41. Kmietowicz Z. Boys in England to get HPV vaccine from next year. BMJ 2018;362:k3237
42. Centers for Disease Control and Prevention. HPV vaccines: vaccinating your preteen or teen. 2018. https://www.cdc.gov/
43. Rao A, Bunker CB. Male genital skin biopsy. Int J STD AIDS. 2011;22:418-419.
45. Bauer A, Geier J, Elsner P. Allergic contact dermatitis in patients with anogenital complaints. J Repro Med. 2000;45:649-654.
46. Bunker CB. Re: Sanjay Kulkarni, Guido Barbagli, Deepak Kirpekar, et al. Lichen sclerosus of the male genitalia and urethra: surgical options and results in a multicenter international experience with 215 patients. Eur Urol 2009;55:945-56. Eur Urol. 2010;58:e55-e56.
47. Kravvas G, Shim TN, Doiron PR, et al. The diagnosis and management of male genital lichen sclerosus: a retrospective review of 301 patients. J Eur Acad Dermatol Venereol. 2018;32(1):91-95.
48. Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists' guidelines for the management of lichen sclerosus 2018. Br J Dermatol. 2018;178:839-853.
49. Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1-137.
50. Bunker CB, Neill S, Staughton RC. Topical tacrolimus, genital lichen sclerosus, and risk of squamous cell carcinoma. Arch Dermatol. 2004;140:1169.
51. Bunker CB. Male genital lichen sclerosus and tacrolimus. Br J Dermatol. 2007;157:1079-1080.
52. Kidd LC, Chaing S, Chipollini J et al. Relationship between human papillomavirus and penile cancer—implications for prevention and treatment. Transl Androl Urol. 2017;6(5):791–802.
53. Doiron PR, Bunker CB. Expanding the benefits of HPV vaccination to boys and men. Lancet. 2016;388:659.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台